Xconomy

AUGUST 26, 2016

Mylan bumped up the price of the EpiPen 400 percent, presidential nominee Hillary Clinton responded with a tirade against drug price hikes, and—much like when Clinton railed against drug pricing last year—biotech indexes promptly plummeted more than 3 percent. It was the tweet heard around the biotech world, again.

Pricing 40

Pricing Thousand Oaks Startup Research 40

Xconomy

AUGUST 19, 2016

And once in a while, a defender uses his or her face, inadvertently, to block a ball spiked over the net. Talk about sacrifice. If drug approval were an Olympic sport, rejections would also be high drama. Everyone is waiting until 2017, when huge studies of the drugs’ ability to prevent heart attacks and strokes start to provide data.

Technical Review 40

Technical Review Patents .Net Study 40

Xconomy

NOVEMBER 4, 2016

Its owner Pfizer (NYSE: PFE ) shelved it this week , citing poor Phase 3 data and pricing pressures on the two approved PCSK9 drugs. —Several other biotechs released ASH abstract data, and the net effect was a drop in most stocks. One latecomer, bococizumab, won’t even reach approval. MONEY IN, MONEY OUT.

Research 40

Research Report Pricing Journal 40

SoCal Delicious

OCTOBER 8, 2012

Professor Journal. Student Journal. Prices are soaring in the beachfront communities tech types favor, and rents in these. Mark Holtzman for The Wall Street Journal. Mark Holtzman for The Wall Street Journal). Prices have gone up dramatically on this beachfront strip. MarketWatch. MarketWatch. SmartMoney.

Los Angeles 44

Los Angeles Software Review Technical Review Journal 44